Evidence map›Paper›PMID 26979731›Full record

ArticleParasitology research2016

Carbonic anhydrase enzyme as a potential therapeutic target for experimental trichinellosis.

Abeer E Saad, Dalia S Ashour, Dina M Abou Rayia, Asmaa E Bedeer

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mitigation ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abeer E SaadDepartment of Medical Parasitology, Faculty of Medicine, Tanta University, Tanta, Gharbiya, Egypt. abero2020@yahoo.com.
Dalia S AshourDepartment of Medical Parasitology, Faculty of Medicine, Tanta University, Tanta, Gharbiya, Egypt.
Dina M Abou RayiaDepartment of Medical Parasitology, Faculty of Medicine, Tanta University, Tanta, Gharbiya, Egypt.
Asmaa E BedeerDepartment of Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.
Tanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichinellosis is a globally distributed helminthic infection. There is a considerable interest in developing new anti-helminthic drugs affecting all the developmental stages of Trichinella. Acetazolamide (carbonic anhydrase (CA) inhibitor) involves a novel mechanism of action by inhibiting such an essential enzyme for parasite metabolism. This work aimed to study the effect of acetazolamide against different stages of T. spiralis in experimental animals. Mice were divided into three groups: group I: infected and treated with acetazolamide on day 2 post infection (P.I.), group II: infected and treated with acetazolamide on day 12 P.I., and group III: infected non-treated. From each group, small intestine and muscles were removed for histopathological and immunohistochemical studies. Also, total adult and muscle larval count were estimated. We found that acetazolamide was effective in reduction of both adult and muscle larval counts. When given early, the effect was more pronounced on the adults (62.7 %). However, the efficacy of the drug against muscle larvae was increased when given late (63 %). Improvement of the intestinal histopathological changes was observed in all the treated groups. Degeneration of encysted larvae with minimal pathologic changes of infected skeletal muscle was observed in the treated groups. Expression of matrix metalloproteinase-9 showed a statistically significant decrease in the intestinal and muscle tissues in all treated groups as compared to the control group. In conclusion, the present study revealed that acetazolamide, carbonic anhydrase inhibitor, could be a promising drug against both adults and larvae of T. spiralis.

Indexed as

AcetazolamideAnimalsCarbonic Anhydrase InhibitorsCarbonic AnhydrasesDisease Models, AnimalFemaleHelminth ProteinsHumansIntestine, SmallLarvaMaleMiceMuscle, SkeletalTrichinellaTrichinella spiralisTrichinellosisAcetazolamideCarbonic Anhydrase InhibitorsCarbonic AnhydrasesHelminth ProteinsAcetazolamideCarbonic anhydrase enzymeMatrix metalloproteinasesTrichinella spiralis

Identifiers

PMID26979731
OpenAlexW2301224605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.